Medscape

Persistent Erythema, Telangiectases, and Facial Flushing After Carcinoid Tumor Excision

A 26-year-old woman with an uneventful family medical history presented for evaluation and treatment of a facial dermatosis of 6 years duration. Examination revealed an intense erythema symmetrically ...
Becker's Hospital Review

Lexicon earns FDA approval for carcinoid syndrome diarrhea drug

Carcinoid syndrome is a rare condition that occurs in patients with gastrointestinal tumors. These patients secrete an excessive amount of serotonin, which can lead to symptoms like frequent diarrhea, ...
Nasdaq

Crinetics Initiates Phase 3 Trial Of Paltusotine For A New Indication In Carcinoid Syndrome

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) has begun its pivotal Phase 3 trial of Paltusotine in adults with carcinoid syndrome, dubbed CAREFNDR. Carcinoid syndrome affects about 20% of ...
Seeking Alpha

COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors

DUBLIN, Ireland, and Boston MA, December 19, 2022 Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for ...
Seeking Alpha

Crinetics reports encouraging Phase 2 data for carcinoid syndrome drug

Crinetics Pharmaceuticals (NASDAQ:CRNX) shares rose 6% in post-market trading Tuesday after the company released encouraging topline results from a Phase 2 study of its drug paltusotine in the ...